Abstract
The 122 patients with liver cirrhosis (LC) were examined. The markers of HBV, HDV and HCV have been revealed in 82% patients with LC. The first place in LC etiological structure takes chronic liver diseases with HCV markers. More severe clinical course of LC with HBV/HCV, HBV/HDV/HCV markers combinations, LC with active replication of HBV and LC D have been observed. More favorable clinical course of LC with HCV markers and HBV seroconversion markers have been observed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
